Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Weiner

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Science Translational Medicine|July 15, 2026
A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's diseaseAarash Bordbar, Bernard Bloem, Colton Lloyd, et al.
American Journal of Obstetrics & Gynecology MFM|May 21, 2022
Prophylactic endovascular internal iliac balloon placement during cesarean hysterectomy for placenta accreta spectrumEve Overton, Whitney A Booker, Mirella Mourad, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2006
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonistKimberly E Vanover, David M Weiner, Malath Makhay, et al.
Journal of Hematology & Oncology|July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort studyNarendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Science Translational Medicine|July 15, 2026
A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's diseaseAarash Bordbar, Bernard Bloem, Colton Lloyd, et al.
American Journal of Obstetrics & Gynecology MFM|May 21, 2022
Prophylactic endovascular internal iliac balloon placement during cesarean hysterectomy for placenta accreta spectrumEve Overton, Whitney A Booker, Mirella Mourad, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2006
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonistKimberly E Vanover, David M Weiner, Malath Makhay, et al.
Journal of Hematology & Oncology|July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort studyNarendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Pageof 4